Individualized treatment of chronic hepatitis C: from research to clinical practice.
Scaglione
F
F
Department of Pharmacology, Chemotherapy and Toxicology, School of Medicine, University of Milan, Italy. Francesco.scaglione@unimi.it
Gonzàlez
A
A
Rizzetto
M
M
Soriano
V
V
D016174:Hepacivirus / Q000502:physiology; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a